ACCORDING to Bayer AG, more than 80% of consumers globally want more personalised healthcare and tools to help predict and prevent illness along with better ways to manage their health.
To address this demand, the company has set up a Precision Health business, which will sit within the Consumer Health division and identify "digital and digital-supported consumer healthcare opportunities," the head of R&D and Chief Scientific Officer David Evendon-Challis said.
"Working with start-up companies and other digital health providers while also improving Bayer's existing digital capabilities, Precision Health is about offering a holistic and personalised approach to self-care that increases trust in the company's consumer health brands," the R&D chief said.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Jul 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Jul 23
Warning: Undefined variable $o_shortcode_atts in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1263
Warning: Undefined variable $output in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1266
